Deferred Tax Assets, Valuation Allowance of ImageneBio, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ImageneBio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • ImageneBio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $91,556,000, a 165% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ImageneBio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $91,556,000 +$56,983,000 +165% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q4 2024 $34,573,000 -$66,648,000 -66% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q4 2023 $101,221,000 +$41,188,000 +69% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $60,033,000 +$22,006,000 +58% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q4 2021 $38,027,000 +$10,993,000 +41% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q4 2020 $27,034,000 31 Dec 2020 10-K 17 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.